Highlights Newsletter 1

This newsletter presents you the following key sessions:

1. PODCAST with dr. Zev Wainberg about preliminary data from a phase 1b trial evaluating the safety
    and efficacy of tiragolumab combined with atezolizumab for patients with metastatic oesophageal cancer

2. Adjuvant nab-paclitaxel plus gemcitabine prolongs survival in resected pancreatic cancer

3. Promising overall response and disease control with tumour treating fields combined with sorafenib
    in hepatocellular carcinoma

4. Confirmed safety and efficacy of trifluridine/tipiracil in patients with metastatic colorectal cancer

5. Long-term benefit of nivolumab plus low-dose ipilimumab in previously treated patients with
    MSI-H/dMMR metastatic colorectal cancer